Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
NCT06652516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-10-22
Summary
This study aims at comparing centrifugation based therapeutic plasma exchange (cTPE) versus membrane based therapeutic plasma exchange (mTPE) as regards performance, effectiveness and adverse events in patients indicated for TPE.
Conditions
- Therapeutic Plasma Exchange
Interventions
- PROCEDURE
-
plasma exchange
comparison between the 2 methods of plasma exchange as regards efficacy, performance and adverse events. Procedure of therapeutic plasma exchange (TPE) : mTPE will be done by bellco hemodialysis machine (Formula 2000), while cTPE will be done by Nigale Plasma Collector (XJC 2000). The vascular access used for both types of plasma exchange will be central venous catheter inserted into the internal jugular vein, subclavian or femoral vein. Prescription of TPE The amount of plasma to be treated is usually equivalent to the patient's estimated plasma volume (EPV). Estimated plasma volume will be calculated using the following formula (Kaplan formula) in litres: * EPV = 0.07 x wt (kg) x (1 - hematocrit) in males. * EPV = 0.065 x wt (kg) x (1 - hematocrit) in females.
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Principal Investigators
-
Hesham A Elghoneimy, MD · Department of internal medicine, nephrology unit, Alexandria faculty of medicine, Egypt
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-05
- Primary Completion
- 2023-09-10
- Completion
- 2023-12-08
Countries
- Egypt
Study Locations
More Related Trials
-
Analysis of TPE Treatments With multiFiltratePRO
NCT06272084 ·Status: RECRUITING
-
A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.
NCT06534255 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19
NCT04613986 ·Status: UNKNOWN ·Phase: NA
-
Explore the Relationship Between Platelet Count and Bleeding Score in ITP
NCT06273956 ·Status: RECRUITING
-
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
NCT00128713 ·Status: COMPLETED ·Phase: PHASE3
-
ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
NCT02838992 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
NCT01955811 ·Status: COMPLETED ·Phase: PHASE4
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies
NCT05935202 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
NCT01808521 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
American Trial Using Tranexamic Acid in Thrombocytopenia
NCT02578901 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
NCT02065882 ·Status: COMPLETED ·Phase: PHASE3
-
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346 ·Status: RECRUITING ·Phase: PHASE3
-
Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .
NCT05850481 ·Status: UNKNOWN
-
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
NCT02912884 ·Status: COMPLETED
-
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
NCT03492515 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT04915287 ·Status: UNKNOWN ·Phase: PHASE4
-
Italian Platelet Technology Assessment Study
NCT01642563 ·Status: TERMINATED ·Phase: PHASE3
-
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
NCT06281327 ·Status: RECRUITING ·Phase: PHASE2
-
Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets
NCT05111028 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP
NCT04943042 ·Status: COMPLETED